First Hawaiian Bank Neurocrine Biosciences Inc Transaction History

First Hawaiian Bank

$2.84 Billion
Q1 2025

A detailed history of First Hawaiian Bank transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, First Hawaiian Bank holds 6,550 shares of NBIX stock, worth $664,039. This represents 0.03% of its overall portfolio holdings.

Number of Shares

6,550

Previous 12,243 46.5%

Holding current value

$664,039

Previous $1.67 Million 56.67%

% of portfolio

0.03%

Previous 0.06%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 03, 2025	SELL	$107.22 - $153.29 $610,403 - $872,679	-5,693 Reduced 46.5%	6,550 $724,000
Q4 2024 Jan 08, 2025	BUY	$111.62 - $139.44 $239,983 - $299,796	2,150 Added 21.3%	12,243 $1.67 Million
Q3 2024 Oct 04, 2024	BUY	$114.58 - $153.15 $528,213 - $706,021	4,610 Added 84.08%	10,093 $1.16 Million
Q2 2024 Jul 02, 2024	BUY	$130.86 - $143.19 $41,875 - $45,820	320 Added 6.2%	5,483 $754,000
Q1 2024 Apr 05, 2024	SELL	$130.4 - $143.74 $13,692 - $15,092	-105 Reduced 1.99%	5,163 $712,000
Q4 2023 Jan 08, 2024	BUY	$106.07 - $132.76 $178,727 - $223,700	1,685 Added 47.03%	5,268 $694,000
Q3 2023 Oct 10, 2023	BUY	$94.02 - $117.1 $84,618 - $105,390	900 Added 33.54%	3,583 $403,000
Q2 2023 Jul 06, 2023	SELL	$89.53 - $104.87 $783,387 - $917,612	-8,750 Reduced 76.53%	2,683 $253,000
Q1 2023 Apr 18, 2023	SELL	$94.11 - $123.02 $300,681 - $393,048	-3,195 Reduced 21.84%	11,433 $1.16 Million
Q4 2022 Jan 12, 2023	SELL	$106.72 - $127.06 $69,368 - $82,589	-650 Reduced 4.25%	14,628 $1.75 Million
Q3 2022 Oct 05, 2022	BUY	$92.03 - $107.81 $1,380 - $1,617	15 Added 0.1%	15,278 $1.62 Million
Q2 2022 Jul 22, 2022	BUY	$75.79 - $100.07 $487,708 - $643,950	6,435 Added 72.89%	15,263 $1.49 Million
Q1 2022 Apr 06, 2022	BUY	$72.45 - $94.81 $2,535 - $3,318	35 Added 0.4%	8,828 $827,000
Q4 2021 Jan 12, 2022	BUY	$79.65 - $106.22 $700,362 - $933,992	8,793 New	8,793 $749,000
Q1 2021 Apr 09, 2021	SELL	$87.57 - $119.4 $269,540 - $367,513	-3,078 Closed	0 $0
Q4 2020 Jan 12, 2021	SELL	$86.91 - $108.33 $12,601 - $15,707	-145 Reduced 4.5%	3,078 $295,000
Q3 2020 Oct 06, 2020	BUY	$96.16 - $135.15 $309,923 - $435,588	3,223 New	3,223 $310,000
Q2 2019 Jul 15, 2019	SELL	$72.24 - $91.27 $9,174 - $11,591	-127 Closed	0 $0
Q1 2019 Apr 02, 2019	SELL	$69.31 - $91.53 $16,703 - $22,058	-241 Reduced 65.49%	127 $11,000
Q4 2018 Jan 11, 2019	BUY	$68.32 - $124.36 $3,962 - $7,212	58 Added 18.71%	368 $26,000
Q3 2018 Oct 16, 2018	BUY	$98.88 - $125.85 $30,652 - $39,013	310 New	310 $38,000

Others Institutions Holding NBIX

# of Institutions

656

Shares Held

95.9M

Call Options Held

282K

Put Options Held

281K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $9.7B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Hawaiian Bank, based on Form 13F filings with the SEC.

News

Stay updated on First Hawaiian Bank with notifications on news.

Account

First Hawaiian Bank Neurocrine Biosciences Inc Transaction History